期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血管紧张肽Ⅱ受体1拮抗药在快速性心律失常预防和治疗中的作用

Role of angiotensinⅡreceptor 1 antagonist in prevention and treatment of tachyarrhythmia
下载PDF
导出
摘要 血管紧张肽Ⅱ可诱发或加重室性或房性快速性心律失常的发生。血管紧张肽Ⅱ可使心肌纤维化,缩短有效不应期,减慢传导速度,有利于折返激动的形成。血管紧张肽Ⅱ可使交感神经张力增高,有利于自律性增高性快速性室性心律失常的发生。研究表明血管紧张肽Ⅱ受体1拮抗药有一定的预防和治疗心律失常的作用。 Angiotension Ⅱ can induce or aggravate ventricular or atrial tachyarrhythmia. Angiotension Ⅱ can cause cardiac fibrosis, shorten effective refractory period, and reduce conduction velocity, which improves the formation of reentry. Angiotension Ⅱcan increase the activity of sympathetic nerve system, and contribute to the occurrence of automatic ventricular tachyarrhythmia. The researches showed that angiotensin Ⅱ receptor 1 antagonist played some role in the prevention and treatment of arrhythmia.
作者 黄震华
机构地区 上海交通大学医学院附属第九人民医院心血管病研究室
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2008年第2期136-139,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 肾素-血管紧张肽系统 受体 心律失常 renin-angiotension system receptor arrhythmia
分类号 R541.7 [医药卫生—心血管疾病]
  • 相关文献

参考文献19

  • 1FERRARIO CM. Role of angiotensin Ⅱ in cardiovascular disease therapeutic implications of more than a century of research[J]. J Renin Angiotensin Aldosterone Syst, 2006, 7(1): 3-14.
  • 2UNGER T. The role of the rennin-angiotensin system in the development of cardiovascular disease[J]. Am J Cardiol, 2002, 89(2A) : 3A-9A.
  • 3NACCARELLA F, NACCARELLI GV, MARANGA SS, et al. Do ACE inhibitors or angiotensin Ⅱ antagonists reduced total mortality and arrhythmic mortality? A critical review of controlled clinical trials[J]. Curt Opin Cardiol, 2002, 17(1):6-18.
  • 4GARG S, NARULA J, MARELLI C, et al. Role of angiotensin receptor blockers in the prevention and treatment of arrhythmias [J]. Am J Cardiol, 2006, 97(6) : 921-925.
  • 5MARUYAMA R, HATTA E, YASUDA K, et al. Angiotensinconverting enzyme-independent angiotensin formation in a human model of myocardial ischemia: modulation of norepinephfine release by angiotensin type 1 and angiotensin type 2 receptors[J]. J Pharmacol Exp Ther, 2000, 294(1):248-254.
  • 6NAKASHIMA H, KUMAGAI K, URATA H, et al. Angiotensin Ⅱ antagonist prevents electrical remodeling in atrial fibrillation [J]. Circulation, 2000, 101(22): 2612-2617.
  • 7BRUNDEL BJ, HENNING RH, KAMPINGA HH, et al. Molecular mechanisms of remodeling in human atrial fibrillation [J]. Cardiovasc Res, 2002, 54(2): 315-324.
  • 8SHINAGAWA K, MITAMURA H, OGAWA S, et al. Effects of inhibiting Na (+)/H(+)-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling[J]. Cardiovasc Res, 2002, 54(2): 438-446.
  • 9CARDIN S, LI D, THORIN-TRESCASES N, et al. Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and-independent pathways[J]. Cardiovasc Res, 2003, 60(2): 315-325.
  • 10de BOER RA, van GEEL PP, PINTO YM, et al. Efficacy of angiotensin Ⅱ type 1 receptor blockade on reperfusion-induced arrhythmias and mortality early after myocardial infarction is increased in transgenic rats with cardiac angiotensin Ⅱ type 1 overexpression[J]. J Cardiovasc Pharmaeol, 2002, 39(4):610-619.
中国新药与临床杂志
2008年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部